<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03861611</url>
  </required_header>
  <id_info>
    <org_study_id>2019-10026</org_study_id>
    <nct_id>NCT03861611</nct_id>
  </id_info>
  <brief_title>A Comparison of NSAIDs for Acute, Non-radicular Low Back Pain.</brief_title>
  <official_title>A Comparison of NSAIDs for Acute, Non-radicular Low Back Pain. A Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: This is a randomized clinical trial comparing the effects of three different&#xD;
      medications for acute low back pain (LBP):Ketorolac, Ibuprofen, Diclofenac&#xD;
&#xD;
      Hypothesis: A daily regimen of ketorolac will provide greater relief of LBP than ibuprofen or&#xD;
      diclofenac 5 days after an emergency department (ED) visit, as measured by the Roland Morris&#xD;
      Disability Questionnaire (RMQ)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      More than 2.5 million patients present to US emergency departments (ED) annually with low&#xD;
      back pain. Up to half of ED patients with acute, new onset low back pain (LBP) report&#xD;
      persistent moderate or severe pain one week after the ED visit. Non-steroidal&#xD;
      anti-inflammatory drugs (NSAIDs) are an effective treatment of acute LBP, though their impact&#xD;
      is only modest.Given the poor pain and functional outcomes that persist beyond an ED visit&#xD;
      for acute LBP, this clinical trial proposes to determine whether there is a difference in&#xD;
      efficacy between the NSAIDs ketorolac, ibuprofen, and diclofenac and for the treatment of&#xD;
      acute, non-traumatic, non-radicular low back pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 12, 2019</start_date>
  <completion_date type="Actual">February 2, 2021</completion_date>
  <primary_completion_date type="Actual">February 2, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline to Day 5 in Functional Impairment</measure>
    <time_frame>Baseline to 5 days</time_frame>
    <description>The change will be assessed by Roland Morris Disability Questionnaire between the baseline ED visit and the five day follow-up. The Roland-Morris Questionnaire (RMQ) is a self-administered disability measure in which greater levels of disability are reflected by higher numbers on a 24-point scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Worsening LBP after ED visit</measure>
    <time_frame>48 hours and 5 days after Emergency department visit</time_frame>
    <description>Worsening LBP over the previous 24 hours, using a four point ordinal scale: severe, moderate, mild, or none</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of LBP after ED visit</measure>
    <time_frame>48 hours and 5 days</time_frame>
    <description>Frequency will be assessed using the five point Likert scale: Not at all, Rarely, Sometimes, Usually, Always</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic or NSAID usage</measure>
    <time_frame>24 hours to 5 days</time_frame>
    <description>Usage of NSAID and analgesic medications</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">198</enrollment>
  <condition>Back Pain Without Radiation</condition>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Ketorolac + Educational Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants may be randomized to receive Ketorolac for their LBP. Research personnel will provide each participant with a 15-minute educational intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen + Educational Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants may be randomized to receive Ibuprofen for their LBP. Research personnel will provide each participant with a 15-minute educational intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diclofenac + Educational Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants may be randomized to receive diclofenac for their LBP. Research personnel will provide each participant with a 15-minute educational intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac</intervention_name>
    <description>Participants may be randomized to receive Ketorolac oral medication 10 mg, every 8 hours for 5 days as needed</description>
    <arm_group_label>Ketorolac + Educational Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>Participants may be randomized to receive Ibuprofen oral medication 600 mg, every 8 hours for 5 days as needed</description>
    <arm_group_label>Ibuprofen + Educational Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac</intervention_name>
    <description>Participants may be randomized to receive Diflofenac oral medication 50 mg, every 8 hours for 5 days as needed</description>
    <arm_group_label>Diclofenac + Educational Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Educational Intervention</intervention_name>
    <description>Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp)</description>
    <arm_group_label>Diclofenac + Educational Intervention</arm_group_label>
    <arm_group_label>Ibuprofen + Educational Intervention</arm_group_label>
    <arm_group_label>Ketorolac + Educational Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men or women age 18-64.&#xD;
&#xD;
          -  Present to ED primary for management of Low Back Pain (LBP)&#xD;
&#xD;
          -  Functionally impairing back pain: A baseline score of greater than 5 on the&#xD;
             Roland-Morris Disability Questionnaire&#xD;
&#xD;
          -  Musculoskeletal etiology of low back.&#xD;
&#xD;
          -  Non-radicular pain.&#xD;
&#xD;
          -  Pain duration &lt;2 weeks (336 hours).&#xD;
&#xD;
          -  Non-traumatic LBP&#xD;
&#xD;
          -  Participant is to be discharged home.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Flank pain, that is pain originating from tissues lateral to the paraspinal muscles.&#xD;
&#xD;
          -  Not available for follow-up&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Chronic pain syndrome&#xD;
&#xD;
          -  Allergic to or intolerant of investigational medications&#xD;
&#xD;
          -  Contra-indications to investigational medications&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eddie Irizarry, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 1, 2019</study_first_submitted>
  <study_first_submitted_qc>March 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2019</study_first_posted>
  <last_update_submitted>February 4, 2021</last_update_submitted>
  <last_update_submitted_qc>February 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Eddie Irizarry</investigator_full_name>
    <investigator_title>Assistant Professor of Emergency Medicine</investigator_title>
  </responsible_party>
  <keyword>ketorolac</keyword>
  <keyword>diclofenac</keyword>
  <keyword>ibuprofen</keyword>
  <keyword>low back pain</keyword>
  <keyword>back pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan to share</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

